158 related articles for article (PubMed ID: 11236223)
1. Hypopigmented mycosis fungoides: a report of 7 cases and review of the literature.
Stone ML; Styles AR; Cockerell CJ; Pandya AG
Cutis; 2001 Feb; 67(2):133-8. PubMed ID: 11236223
[TBL] [Abstract][Full Text] [Related]
2. Hypopigmented mycosis fungoides: treatment and a 6(1/2)-year follow-up of 9 patients.
Akaraphanth R; Douglass MC; Lim HW
J Am Acad Dermatol; 2000 Jan; 42(1 Pt 1):33-9. PubMed ID: 10607317
[TBL] [Abstract][Full Text] [Related]
3. [Hypopigmented mycosis fungoides].
Robert C; Bahlouli Z; Chemaly P; Flageul B; Blanchet-Bardon C; Dubertret L
Ann Dermatol Venereol; 1995; 122(10):704-6. PubMed ID: 8687060
[TBL] [Abstract][Full Text] [Related]
4. Small malignant melanoma in patients with mycosis fungoides.
Amichai B; Grunwald MH; Goldstein J; Finkelstein E; Halevy S
J Eur Acad Dermatol Venereol; 1998 Sep; 11(2):155-7. PubMed ID: 9784043
[TBL] [Abstract][Full Text] [Related]
5. Hypopigmented mycosis fungoides.
Whitmore SE; Simmons-O'Brien E; Rotter FS
Arch Dermatol; 1994 Apr; 130(4):476-80. PubMed ID: 8166485
[TBL] [Abstract][Full Text] [Related]
6. Mycosis fungoides presenting as areas of hypopigmentation: a report of three cases.
Zackheim HS; Epstein EH; Grekin DA; McNutt NS
J Am Acad Dermatol; 1982 Mar; 6(3):340-5. PubMed ID: 7068962
[TBL] [Abstract][Full Text] [Related]
7. Total skin electron beam therapy with or without adjuvant topical nitrogen mustard or nitrogen mustard alone as initial treatment of T2 and T3 mycosis fungoides.
Chinn DM; Chow S; Kim YH; Hoppe RT
Int J Radiat Oncol Biol Phys; 1999 Mar; 43(5):951-8. PubMed ID: 10192339
[TBL] [Abstract][Full Text] [Related]
8. Hypopigmented mycosis fungoides in a white female.
Amichai B; Grunwald MH; Avinoach I; Halevy S
J Dermatol; 1996 Jun; 23(6):425-6. PubMed ID: 8708157
[TBL] [Abstract][Full Text] [Related]
9. Hypopigmented mycosis fungoides.
Handfield-Jones SE; Smith NP; Breathnach SM
Clin Exp Dermatol; 1992 Sep; 17(5):374-5. PubMed ID: 1458652
[TBL] [Abstract][Full Text] [Related]
10. Mycosis fungoides in young patients: clinical characteristics and outcome.
Crowley JJ; Nikko A; Varghese A; Hoppe RT; Kim YH
J Am Acad Dermatol; 1998 May; 38(5 Pt 1):696-701. PubMed ID: 9591813
[TBL] [Abstract][Full Text] [Related]
11. Hypopigmented variant of mycosis fungoides: demography, histopathology, and treatment of seven cases.
Lambroza E; Cohen SR; Phelps R; Lebwohl M; Braverman IM; DiCostanzo D
J Am Acad Dermatol; 1995 Jun; 32(6):987-93. PubMed ID: 7751470
[TBL] [Abstract][Full Text] [Related]
12. Hypopigmented mycosis fungoides in childhood and adolescence.
Neuhaus IM; Ramos-Caro FA; Hassanein AM
Pediatr Dermatol; 2000; 17(5):403-6. PubMed ID: 11085673
[TBL] [Abstract][Full Text] [Related]
13. Hypopigmented mycosis fungoides. Speculations about the mechanism of hypopigmentation.
Goldberg DJ; Schinella RS; Kechijian P
Am J Dermatopathol; 1986 Aug; 8(4):326-30. PubMed ID: 3766921
[TBL] [Abstract][Full Text] [Related]
14. Milia in regressing plaques of mycosis fungoides: provoked by topical nitrogen mustard or not?
Kalayciyan A; Oguz O; Demirkesen C; Serdaroglu S; Kotogyan A
Int J Dermatol; 2004 Dec; 43(12):953-6. PubMed ID: 15569030
[TBL] [Abstract][Full Text] [Related]
15. Mechlorethamine gel for the topical treatment of stage IA and IB mycosis fungoides-type cutaneous T-cell lymphoma.
Talpur R; Venkatarajan S; Duvic M
Expert Rev Clin Pharmacol; 2014 Sep; 7(5):591-7. PubMed ID: 25068889
[TBL] [Abstract][Full Text] [Related]
16. Topical chemotherapy in cutaneous T-cell lymphoma: positive results of a randomized, controlled, multicenter trial testing the efficacy and safety of a novel mechlorethamine, 0.02%, gel in mycosis fungoides.
Lessin SR; Duvic M; Guitart J; Pandya AG; Strober BE; Olsen EA; Hull CM; Knobler EH; Rook AH; Kim EJ; Naylor MF; Adelson DM; Kimball AB; Wood GS; Sundram U; Wu H; Kim YH
JAMA Dermatol; 2013 Jan; 149(1):25-32. PubMed ID: 23069814
[TBL] [Abstract][Full Text] [Related]
17. The Stanford University experience with conventional-dose, total skin electron-beam therapy in the treatment of generalized patch or plaque (T2) and tumor (T3) mycosis fungoides.
Navi D; Riaz N; Levin YS; Sullivan NC; Kim YH; Hoppe RT
Arch Dermatol; 2011 May; 147(5):561-7. PubMed ID: 21576575
[TBL] [Abstract][Full Text] [Related]
18. Follicular mycosis fungoides: a case report and review of the literature.
DeBloom J; Severson J; Gaspari A; Scott G
J Cutan Pathol; 2001 Jul; 28(6):318-24. PubMed ID: 11401680
[TBL] [Abstract][Full Text] [Related]
19. Treatment of pruritus in early-stage hypopigmented mycosis fungoides with aprepitant.
Jiménez Gallo D; Albarrán Planelles C; Linares Barrios M; Fernández Anguita MJ; Márquez Enríquez J; Rodríguez Mateos ME
Dermatol Ther; 2014; 27(3):178-82. PubMed ID: 24517320
[TBL] [Abstract][Full Text] [Related]
20. Hypopigmented mycosis fungoides: a retrospective clinicohistopathologic study.
Rodney IJ; Kindred C; Angra K; Qutub ON; Villanueva AR; Halder RM
J Eur Acad Dermatol Venereol; 2017 May; 31(5):808-814. PubMed ID: 27515575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
